GO:1904724 tertiary granule lumen: Components, Assembly and Research Methods

Research-grade guide for scientists and biopharma professionals

Key Takeaways

GO:1904724 (tertiary granule lumen) is a cellular_component term defined as any membrane-enclosed lumen that is part of a tertiary granule.
Tertiary granules are secretory organelles of neutrophils and other leukocytes that store matrix metalloproteinases such as MMP9 (gelatinase B) and are mobilized during inflammation.
The lumen is topologically equivalent to the extracellular space and receives cargo through the secretory protein trafficking pathway.
Dysregulated tertiary granule exocytosis contributes to tissue damage in inflammatory diseases and to cancer progression.
Key protein markers include MMP9, MMP25, LCN2, ITGAM, and CDA, which are delivered to the lumen via vesicular transport.
CRISPR knockout, knock-in, and overexpression models enable causal testing of tertiary granule lumen components in immune and cancer biology.

Description

GO:1904724, tertiary granule lumen, is a Gene Ontology cellular_component term describing the membrane-enclosed lumen that is part of a tertiary granule. Tertiary granules are secretory vesicles found in neutrophils and other leukocytes; their lumen is a specialized compartment that stores and releases matrix metalloproteinases and other effector proteins during the inflammatory response. Because the lumen is topologically distinct from the cytosol, its contents are delivered through the secretory protein trafficking pathway, a process that has been dissected genetically and biochemically. Researchers study this compartment to understand how immune cells mobilize degradative enzymes, how cargo is sorted into tertiary granules, and how defects in these processes contribute to inflammatory and malignant disease. The term is therefore central to cell biology, immunology, and translational research on granule-mediated tissue remodeling.

tertiary granule lumen At A Glance

GO ID GO:1904724
GO term tertiary granule lumen
Ontology cellular_component
Synonym gelatinase granule membrane-enclosed lumen; membrane-enclosed lumen of gelatinase granule; membrane-enclosed lumen of tertiary granule; tertiary granule membrane-enclosed lumen
Major function Stores and releases matrix metalloproteinases and other effector proteins during inflammation and tissue remodeling
Parent structure tertiary granule
Cellular context Neutrophils, other leukocytes, and related secretory cells
Topology Membrane-enclosed lumen topologically equivalent to the extracellular space
Research relevance Inflammatory disease, cancer progression, and secretory trafficking

What Is GO:1904724?

According to the Gene Ontology, tertiary granule lumen (GO:1904724) is any membrane-enclosed lumen that is part of a tertiary granule. In other words, it is the interior aqueous space enclosed by the tertiary granule membrane, where secretory cargo such as matrix metalloproteinases accumulates before exocytosis. The term is a cellular_component and is synonymous with gelatinase granule membrane-enclosed lumen, membrane-enclosed lumen of gelatinase granule, membrane-enclosed lumen of tertiary granule, and tertiary granule membrane-enclosed lumen.

Why Is tertiary granule lumen Important in Cell Biology?

The tertiary granule lumen is important because it is the storage compartment for gelatinase B (MMP9) and other proteases that drive extracellular matrix degradation during inflammation and tumor progression. Understanding how cargo is delivered to this lumen and how exocytosis is triggered provides mechanistic insight into immune cell function and identifies potential therapeutic targets in inflammatory and malignant diseases.
Provides a dedicated storage compartment for MMP9 and related proteases in neutrophils.
Enables rapid mobilization of degradative enzymes during the inflammatory response.
Contributes to extracellular matrix remodeling in cancer and chronic inflammation.
Serves as a model for studying secretory protein trafficking and granule biogenesis.
Its cargo proteins are candidate biomarkers in sepsis and breast cancer.
Dysregulated exocytosis can cause collateral tissue damage in inflammatory disease.
Offers targets for anti-inflammatory and anti-metastatic therapeutic strategies.
Enables CRISPR-based dissection of granule cargo sorting and release.

What Happens During tertiary granule lumen?

Cargo delivery to the tertiary granule lumen
In simple terms: Proteins destined for the granule lumen are made in the endoplasmic reticulum and travel through the secretory pathway to reach the granule.
Secretory proteins such as MMP9 are synthesized in the endoplasmic reticulum, transported through the Golgi apparatus, and packaged into nascent tertiary granules. The lumen receives these cargo molecules via vesicular transport, a process that has been analyzed genetically and biochemically in model secretory cells. The membrane-enclosed nature of the lumen ensures that cargo is separated from the cytosol until exocytosis is triggered.
Maturation and storage of granule contents
In simple terms: Once inside the granule, the cargo is stored in a concentrated form until the cell receives a signal to release it.
After delivery, the tertiary granule lumen accumulates matrix metalloproteinases and other effector proteins. The low pH and specific ionic environment of the granule lumen support the storage of these enzymes in an inactive or partially active state until secretion is triggered. This storage function is essential for rapid deployment of proteases during inflammation.
Exocytosis and release of lumenal contents
In simple terms: When the cell is activated, the granule fuses with the plasma membrane and dumps its contents outside the cell.
Upon stimulation, tertiary granules undergo exocytosis, fusing with the plasma membrane and releasing their lumenal contents into the extracellular space. This process is tightly regulated and allows neutrophils to degrade extracellular matrix components and combat pathogens. The released proteases can also contribute to tissue damage in inflammatory diseases.
Recycling and membrane retrieval
In simple terms: After secretion, the granule membrane components can be retrieved and reused by the cell.
Following exocytosis, membrane proteins and lipids from the tertiary granule are internalized and recycled back to intracellular compartments. This retrieval process helps maintain granule homeostasis and ensures that the cell can respond to subsequent stimuli. Defects in membrane recycling can impair granule function and contribute to disease.

Key Genes Involved in GO:1904724 tertiary granule lumen

The following genes encode proteins that are either cargo of the tertiary granule lumen or regulators of its biogenesis and exocytosis.
GeneMajor RoleResearch Relevance
MMP9Matrix metalloproteinase cargo stored in tertiary granule lumenMarker of tertiary granules; involved in inflammation and cancer
MMP25Membrane-type matrix metalloproteinase associated with tertiary granulesPotential role in leukocyte migration and tissue remodeling
LCN2Lipocalin 2, a granule lumen proteinInvolved in innate immunity and iron sequestration
ITGAMIntegrin alpha-M, a granule membrane proteinAdhesion and migration of neutrophils
CDACytidine deaminase, a granule lumen enzymeMarker of tertiary granules in leukocytes
STXBP2Syntaxin-binding protein 2, regulates granule exocytosisMutations cause familial hemophagocytic lymphohistiocytosis
RAB27ASmall GTPase required for granule exocytosisDefects cause Griscelli syndrome
UNC13DMunc13-4, essential for granule fusionMutations cause familial hemophagocytic lymphohistiocytosis
SNAP23SNARE protein involved in granule-plasma membrane fusionRegulates exocytosis in immune cells
VAMP7Vesicle-associated membrane protein 7Mediates granule fusion with plasma membrane
ARF6Small GTPase regulating membrane traffickingControls granule exocytosis and recycling
RAB5AEarly endosomal GTPaseParticipates in granule membrane retrieval
RAB11ARecycling endosome GTPaseRegulates granule membrane recycling
SYKSpleen tyrosine kinase, signaling for granule releaseIntegrates immune receptor signals
PRKCDProtein kinase C delta, regulates exocytosisModulates granule release in leukocytes
MAPK1Mitogen-activated protein kinase 1Signaling cascade for granule mobilization
PIK3CDPhosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit deltaControls granule exocytosis in immune cells

How Is tertiary granule lumen Regulated?

The formation and exocytosis of tertiary granule lumen are regulated by signaling pathways that control secretory trafficking. Small GTPases such as RAB27A and ARF6, together with SNARE proteins, orchestrate granule fusion with the plasma membrane. Immune receptor signaling through SYK and protein kinase C isoforms triggers granule mobilization. Phosphoinositide 3-kinase signaling also contributes to granule exocytosis in leukocytes. These regulatory mechanisms ensure that degradative enzymes are released only when needed, preventing collateral tissue damage.

tertiary granule lumen and Human Disease

GeneDisease / BiologyPotential Experimental Model
MMP9Inflammation, cancer metastasisMMP9 knockout neutrophil model
RAB27AGriscelli syndrome, immunodeficiencyRAB27A knockout immune cells
STXBP2Familial hemophagocytic lymphohistiocytosisSTXBP2 point-mutation knock-in
UNC13DFamilial hemophagocytic lymphohistiocytosisUNC13D knockout cell line
LCN2Innate immunity, iron homeostasisLCN2 overexpression model
Tertiary granule lumen in inflammatory disease
Excessive release of matrix metalloproteinases from tertiary granules contributes to tissue destruction in chronic inflammatory conditions such as rheumatoid arthritis and chronic obstructive pulmonary disease. Dysregulated granule exocytosis can also exacerbate acute inflammatory responses. Understanding the lumenal cargo and its regulation may reveal therapeutic targets for limiting inflammatory damage.
Tertiary granule lumen in cancer
Matrix metalloproteinases stored in tertiary granules, particularly MMP9, promote tumor invasion and metastasis by degrading extracellular matrix components. Gene expression signatures associated with granule proteins have been identified in breast cancer and sepsis, suggesting that tertiary granule lumen components may serve as biomarkers or therapeutic targets. Network pharmacology studies have highlighted the role of such proteins in trastuzumab response in breast cancer.
Tertiary granule lumen in immune deficiency
Defects in granule exocytosis machinery, such as mutations in STXBP2, RAB27A, or UNC13D, impair the release of tertiary granule contents and cause immunodeficiency syndromes including familial hemophagocytic lymphohistiocytosis. These disorders underscore the importance of the tertiary granule lumen in host defense.

From tertiary granule lumen-Related Genes to Experimental Models

Research QuestionSuitable Model
Does loss of MMP9 affect tertiary granule lumen cargo release?MMP9 knockout cell line
Does a point mutation in RAB27A impair granule exocytosis?RAB27A point-mutation knock-in
Can tagging endogenous LCN2 reveal lumenal localization?LCN2 tagged knock-in
Does overexpression of MMP9 increase invasive capacity?MMP9 overexpression cell line
Which genes regulate tertiary granule biogenesis?CRISPR library screening
What is the transcriptomic signature of granule-deficient cells?RNA-seq of knockout models

How to Study the tertiary granule lumen Process

MethodWhat It MeasuresTypical Application
ProteomicsProtein composition of granule lumenIdentifying novel cargo proteins
Live-cell imagingDynamics of granule exocytosisVisualizing fusion events
RNA-seqTranscript levels of granule-related genesExpression profiling in disease
ZymographyActivity of matrix metalloproteinasesMeasuring MMP9 release
ELISAConcentration of secreted proteinsQuantifying granule exocytosis
CRISPR screeningGenes required for granule functionIdentifying regulators
Flow cytometrySurface markers of granule exocytosisAssessing degranulation
Proteomic analysis of granule lumen contents
Mass spectrometry-based proteomics can identify proteins enriched in isolated tertiary granules, revealing the composition of the lumen. This approach has been used to catalog granule cargo and to compare normal and diseased cells.
Imaging of granule exocytosis
Live-cell imaging with fluorescently tagged granule markers allows real-time visualization of tertiary granule lumen exocytosis and membrane fusion. Super-resolution microscopy can resolve the spatial organization of granule cargo.
Transcriptomic profiling of granule-related genes
RNA sequencing can quantify expression of genes encoding tertiary granule lumen proteins and regulators, providing insights into their role in disease. Random forest and network pharmacology analyses have identified mRNA signatures associated with sepsis and breast cancer.
Functional assays for granule release
Enzyme-linked immunosorbent assays and zymography can measure the release of MMP9 and other lumenal cargo upon stimulation, assessing granule exocytosis function. These assays are useful for evaluating the impact of genetic perturbations.

How CRISPR Can Be Used to Study GO:1904724 tertiary granule lumen

Knockout

CRISPR knockout of genes encoding tertiary granule lumen cargo or regulatory proteins can abolish granule function and reveal their contribution to inflammation and cancer. For example, MMP9 knockout reduces matrix degradation in neutrophil models.

Point Mutation

Introducing disease-associated point mutations into genes such as RAB27A or STXBP2 allows researchers to model immunodeficiency syndromes and study granule exocytosis defects. These models can reveal how specific amino acid changes affect lumenal cargo release.

Knock-in

Tagged knock-in of granule proteins, such as LCN2 or MMP9, enables real-time tracking of lumenal cargo trafficking and exocytosis. This approach provides spatial and temporal resolution of granule dynamics.

Overexpression

Overexpression of MMP9 or other granule lumen proteins can enhance invasive capacity and matrix degradation, modeling cancer progression. Such models are useful for testing therapeutic inhibitors.

How EDITGENE Supports tertiary granule lumen Research

Researchers studying tertiary granule lumen-related genes often need to determine whether a candidate gene is causally involved in granule biogenesis, cargo sorting, or exocytosis. EDITGENE provides a comprehensive suite of CRISPR services to enable such investigations, from knockout to knock-in and library screening.
Contact EDITGENE today to design your custom CRISPR model for tertiary granule lumen research.

Frequently Asked Questions About tertiary granule lumen

The tertiary granule lumen (GO:1904724) is the membrane-enclosed interior space of a tertiary granule, where secretory cargo such as MMP9 is stored before release.
Key genes include MMP9, MMP25, LCN2, ITGAM, CDA, and regulators of exocytosis such as RAB27A and STXBP2.
It stores and releases matrix metalloproteinases and other effector proteins during inflammation and tissue remodeling.
Inflammatory diseases, cancer metastasis, and immunodeficiency syndromes such as familial hemophagocytic lymphohistiocytosis.
CRISPR knockout, point mutation, knock-in, and overexpression models allow functional dissection of granule cargo and regulatory genes.
The GO ID is GO:1904724, under the cellular_component ontology.
Synonyms include gelatinase granule membrane-enclosed lumen and membrane-enclosed lumen of tertiary granule.
MMP9, MMP25, LCN2, and CDA are among the proteins stored in the tertiary granule lumen.
It is regulated by small GTPases, SNARE proteins, and immune receptor signaling pathways.
Its cargo, particularly MMP9, promotes tumor invasion and metastasis by degrading extracellular matrix.

Conclusion

The tertiary granule lumen (GO:1904724) is a specialized secretory compartment critical for the storage and release of matrix metalloproteinases and other effector proteins in immune cells. Its dysfunction contributes to inflammatory diseases, cancer progression, and immunodeficiency syndromes. Continued research using CRISPR-based models and advanced proteomic and imaging techniques will further elucidate its role in health and disease.

References

  1. 4. Arvan P. 2004. Secretory protein trafficking: genetic and biochemical analysis.. Cell Biochem Biophys 40(3 Suppl):169-78 PMID: 15289652
  2. 5. Zhou J et al.. 2022. Identification of Nine mRNA Signatures for Sepsis Using Random Forest.. Comput Math Methods Med 2022:5650024 PMID: 35345523
  3. 6. Lu Y et al.. 2022. Differential Gene Analysis of Trastuzumab in Breast Cancer Based on Network Pharmacology and Medical Images.. Front Physiol 13:942049 PMID: 35874525
Contact Us
*
*
*
*
How did you hear about us: